Russell Investments Group, Ltd. - NEUBASE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 52 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$160,000
+6.0%
21,6520.0%0.00%–
Q4 2020$151,000
-42.4%
21,652
-37.4%
0.00%
-100.0%
Q3 2020$262,000
+385.2%
34,592
+454.4%
0.00%–
Q2 2020$54,000–6,240–0.00%–
 Download
Other shareholders
NEUBASE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
CARNEGIE MELLON UNIVERSITY 46,970$40,8550.05%
View complete list of NEUBASE THERAPEUTICS INC shareholders